TOG Review (RCOG Journal)
MRCOG Part 2
Urogynaecology and Pelvic Floor Problems
Present status and advances in bladder pain syndrome
Key Statistics
- 2–6% — BPS prevalence (more common in women)
- 45.5–66.0% — Amitriptyline success rate
- ≤50% — Improvement with neuromodulation
Don't-miss facts
-
BPS = interstitial cystitis; chronic bladder-related pain/pressure + ≥1 urinary symptom; prevalence 2–6%, female predominant
-
Peripheral driver: proteoglycan/GAG barrier damage → substance P/CGRP release → peripheral + central sensitisation
-
Exclude ketamine cystitis in any patient presenting with bladder pain and ulceration
-
BPS clusters with central sensitivity syndromes: fibromyalgia, IBS, vulvodynia, migraine, depression/anxiety
-
Amitriptyline success 45.5–66.0%; mean dose 55 mg (range 12.5–150 mg); gabapentinoids unlicensed, no BPS efficacy data
-
RCOG 2016: long-term antibiotics not recommended – despite newer (non-RCT) studies showing benefit and a 90% flare rate on stopping treatment early
-
PTNS: weekly for average 12 weeks; neuromodulation improves up to 50% of patients
-
r-TMS: RCT evidence of benefit in treatment-resistant BPS; DBS not yet used specifically for BPS
Bladder wall injury → sensitisation cascade
Trigger (infection/trauma/childbirth/instrumentation) → GAG barrier disruption Toxic solutes/cytokines permeate → afferent depolarisation, ↑nociceptor channels Substance P + CGRP release → neuropathic pain Persistent input → ↑CNS neuron responsiveness → allodynia/hyperalgesia (central sensitisation)
Abbreviation Key
- BPS — bladder pain syndrome
- r-TMS — repetitive transcranial magnetic stimulation
- IC — interstitial cystitis
- VAS — visual analogue score
- GAG — glycosaminoglycan
- LUTS — lower urinary tract symptoms
- CGRP — calcitonin gene-related peptide
- UTI — urinary tract infection
- CNS — central nervous system
- IBS — irritable bowel syndrome
- PTNS — posterior tibial nerve stimulation
- AUA — American Urological Association
- SNS — sacral nerve stimulation
- RCOG — Royal College of Obstetricians and Gynaecologists
- DBS — deep brain stimulation
Source: Offiah I et al. Present status and advances in bladder pain syndrome: central sensitisation and the urinary microbiome. The Obstetrician & Gynaecologist 2022;24:159–166. doi:10.1111/tog.12807
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).